30 July 2021 On 26 July 2021, EASL submitted its views to a public consultation held by the European Commission (EC) on the establishing of the future European Health Data Space (EHDS). Because it is a priority for the EC…
In early 2016, the EASL Governing Board initiated a new format for its Schools of Hepatology. In September of the same year, the first pilot of this new format was executed successfully and received overwhelmingly positive feedback from participants. The EASL Schools of Hepatology have been running according to this successful structure for…
An Annual Report with a difference, for a year like none other
ClarivateTM Analytics released the 2021 update of its Journal Citation Reports©, including the much anticipated 2020 impact factor. EASL’s flagship monthly journal, the Journal of Hepatology, achieved unprecedented results with a 2020 impact factor of 25.083, up from the 2019…
We would like to thank every single participant who took part in this year's ILC, held 23–26 June 2021. The event brought together almost 6,500 delegates from over 100 countries, who took part in 155 sessions, listened to 566 presentations…
In EASL Studio, we were honoured to keep company with the three 2020 Nobel Laureates, awarded the 2020 Nobel Prize for Physiology and Medicine for their discovery of the hepatitis C virus. They reflected on many thought-provoking topics: the exponential…
Mark your calendars! On 22 of June 2021, the European Association for the Study of Liver disease (EASL) will be releasing the much-anticipated updated guidelines on the use of non-invasive techniques (NITs). These new guidelines will be presented and discussed in a…
8 June 2021 EASL is delighted to be officially endorsing International NASH Day 2021: NASH Around the World, conducted by the Global Liver Institute (GLI), this Thursday, 10 June. Non-alcoholic steatohepatitis (NASH), the advanced form of non-alcoholic fatty liver disease (NAFLD), is a life-threatening disease…
